K. Shanmuganathan

发表

Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents.

R. Schinazi, C. K. Chu, L. Jeong, 1993, Journal of medicinal chemistry.

Pharmacokinetics of the anticancer agent 2-chloro-9-(2-deoxy-2-fluoro-β-d-arabinofuranosyl)adenine in rats

C. K. Chu, J. Gallo, M. Qian, 2004, Cancer Chemotherapy and Pharmacology.

In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.

L. Kotra, R. Schinazi, C. K. Chu, 1996, Journal of Medicinal Chemistry.

Enhanced brain delivery of an anti-HIV nucleoside 2'-F-ara-ddI by xanthine oxidase mediated biotransformation.

R. Schinazi, C. K. Chu, J. Gallo, 1994, Journal of medicinal chemistry.

Structure--activity relationships of 1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)pyrimidine nucleosides as anti-hepatitis B virus agents.

Y. L. Zhu, Y. Cheng, C. K. Chu, 1996, Journal of medicinal chemistry.

Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus

Y. Cheng, C. K. Chu, J. Sommadossi, 1995, Antimicrobial agents and chemotherapy.

Potent anti-HIV and anti-HBV activities of (−)-L-β-dioxolane-C and (+)-L-β-dioxolane-T and their asymmetric syntheses.

R. Schinazi, C. K. Chu, L. Jeong, 1992 .

Chelation controlled allylation of aldehydes with a chiral allylsilylene derived from (−)-10-phenylpinanediol

B. Jensen, L. G. French, K. Shanmuganathan, 1994 .

4-Azido-2-pyrimidinone Nucleosides and Related Chemistry.

L. Kotra, C. K. Chu, PingPing Wang, 1997, The Journal of organic chemistry.

Stereocontrolled Routes for the Synthesis of Anti-HIV and Anti-HBV Nucleosides

C. K. Chu, L. Jeong, Hea Ok Kim, 1993 .

1,3-dioxolanylpurine nucleosides (2R,4R) and (2R,4S) with selective anti-HIV-1 activity in human lymphocytes.

R. Schinazi, C. K. Chu, L. Jeong, 1993, Journal of medicinal chemistry.

and Epstein-Barr virus. l as a novel antiviral agent for hepatitis B virus 2'-fluoro-5-methyl-beta-L-arabinofuranosyluraci Use of

C. K. Chu, J. Sommadossi, Y. Xiang, 2013 .

L-beta-(2S,4S)- and L-alpha-(2S,4R)-dioxolanyl nucleosides as potential anti-HIV agents: asymmetric synthesis and structure-activity relationships.

R. Schinazi, C. K. Chu, L. Jeong, 1993, Journal of medicinal chemistry.

Structure-activity relationships of beta-D-(2S,5R)- and alpha-D-(2S,5S)-1,3-oxathiolanyl nucleosides as potential anti-HIV agents.

R. Schinazi, M. Chun, C. K. Chu, 1993, Journal of medicinal chemistry.

Structure‐Activity Relationships of 1‐(2‐Deoxy‐2‐fluoro‐β‐L‐ arabinofuranosyl)pyrimidine Nucleosides as anti‐Hepatitis B Virus Agents.

Y. L. Zhu, C. K. Chu, H. Kim, 1996 .

Structure-Activity Relationships of β-D-(2S,5R)- and α-D-( 2S,5S)-1,3-Oxathiolanyl Nucleosides as Potential Anti-HIV Agents.

R. Schinazi, M. Chun, C. K. Chu, 1993 .

1,3‐Dioxolanylpurine Nucleosides (2R,4R), e.g. (II), and (2R,4S) with Selective Anti‐HIV‐1 Activity in Human Lymphocytes.

R. Schinazi, C. K. Chu, L. Jeong, 1994 .